Illumina Posts 1 Percent Decline in Q3 Revenues, Plans Restructuring | GenomeWeb

This article has been updated to include additional information from Illumina's conference call.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Illumina today reported that its third-quarter revenues fell 1 percent year over year, in line with the preliminary figure it offered earlier in the month, and it will undertake a restructuring.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.